Eicosatetraynoic Acid (ETYA) CAS 1191-85-1: Comprehensive User Guide
Table of Contents
1. Product Overview & Specifications
Eicosatetraynoic Acid (ETYA) (CAS 1191-85-1) is a non-metabolizable arachidonic acid analog widely used in biochemical research to inhibit both lipoxygenase and cyclooxygenase pathways.
Parameter | ETYA Specification | Comparable Inhibitors |
---|---|---|
CAS Number | 1191-85-1 | N/A |
Molecular Formula | C20H28O2 | Varies by compound |
Molecular Weight | 300.44 g/mol | ~250-350 g/mol |
Purity | ≥98% (HPLC) | Typically 95-99% |
2. Key Applications & Uses
Primary Research Applications:
- Inflammation mechanism studies
- Eicosanoid pathway analysis
- Cell signaling modulation
- Drug discovery platforms
3. Usage Guidelines
Recommended Protocols:
Application | Concentration Range | Solvent Compatibility |
---|---|---|
In Vitro Studies | 10-50 µM | Ethanol/DMSO |
Cell Culture | 5-20 µM | Serum-free media |
4. Research Case Studies
Case 1: Inflammation Pathway Analysis
University researchers utilized ETYA (20 µM) to successfully block prostaglandin synthesis in macrophage cells, leading to breakthrough findings in acute inflammatory response mechanisms.
5. Customer Success Stories
PharmaTech Solutions
"ETYA's dual pathway inhibition proved critical in our rheumatoid arthritis drug discovery program, accelerating lead compound identification by 40%" - Dr. Emily Rodriguez, Lead Researcher
NeuroLab International
"Using ETYA at 15 µM concentration enabled precise modulation of neuronal COX-2 expression in our Alzheimer's disease models" - Prof. Michael Chen, CSO
6. Request Custom Formulations
Contact our technical team for bulk orders or specialized formulations:
info@vivalr.com
(86) 15866781826